Benjamin F McGraw III's Net Worth
$815 Thousand
Who is Benjamin F McGraw III?
Benjamin F McGraw III does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Urigen Pharmaceuticals, Inc., AERIE PHARMACEUTICALS INC, and ISTA PHARMACEUTICALS INC.
SEC CIK
Benjamin F McGraw III's CIK is 0001216994
Past Insider Trading and Trends
2004 was Benjamin F McGraw III's most active year for acquiring shares with 6 total transactions. Benjamin F McGraw III's most active month to acquire stocks was the month of May. 2012 was Benjamin F McGraw III's most active year for disposing of shares, totalling 11 transactions. Benjamin F McGraw III's most active month to dispose stocks was the month of May. 2002 saw Benjamin F McGraw III paying a total of $118,275.00 for 33,000 shares, this is the most they've acquired in one year. In 2022 Benjamin F McGraw III cashed out on 179,374 shares for a total of $1,270,262.68, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Urigen Pharmaceuticals, Inc. No price found
COB, President and CEOBenjamin F McGraw III owns 42,215 units of Common Stock. From 2004 to 2007 Benjamin F McGraw III acquired a total of 59,464 shares in Urigen Pharmaceuticals, Inc., Benjamin also disposed a total of 21,395 shares of Urigen Pharmaceuticals, Inc. equalling to $30,726.89.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -4.03% | -1.77K |
$0.16 | -$283.36 | 42.22K |
Jun 30
| |||
Form 4
| -5.70% | -2.66K |
$0.26 | -$690.82 | 43.99K |
Apr 30
| |||
Form 4
| -6.35% | -3.16K |
$0.26 | -$822.12 | 46.64K |
Jan 31
| |||
Form 4
| -5.06% | -2.66K |
$0.61 | -$1,620.77 | 49.8K |
Oct 31
| |||
Form 4
| -4.82% | -2.66K |
$0.40 | -$1,062.80 | 52.46K |
Jul 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
| -4.60% | -2.66K |
$3.70 | -$9,830.90 | 55.12K |
Apr 30
| |||
Form 4
| -5.21% | -3.18K |
$3.16 | -$10,039.32 | 57.78K |
Jan 31
| |||
Form 4
| -4.18% | -2.66K |
$2.40 | -$6,376.80 | 60.95K |
Oct 31
| |||
Form 4
| +1,434.25% | 59.46K |
—
|
—
| 63.61K |
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 30
| |||
No matching records found |
AERIE PHARMACEUTICALS INC No price found
Interim Executive ChairBenjamin F McGraw III used to own units in Common Stock but no longer holds any shares there. From 2014 to 2022 Benjamin F McGraw III acquired a total of 52,308 shares in AERIE PHARMACEUTICALS INC, Benjamin also disposed a total of 52,308 shares of AERIE PHARMACEUTICALS INC equalling to $725,945.20.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -41.98K |
$15.25 | -$640,256.00 |
0
|
Nov 21
| |||
Form 4
| +17.47% | 6.25K |
—
|
—
| 41.98K |
Jun 9
| |||
Form 4
| -22.41% | -10.32K |
$8.30 | -$85,689.20 | 35.74K |
Feb 28
| |||
Form 4
| +298.81% | 34.51K |
—
|
—
| 46.06K |
Sep 20
| |||
Form 4
| +17.86% | 1.75K |
—
|
—
| 11.55K |
Jun 17
| |||
Form 4
| +21.74% | 1.75K |
—
|
—
| 9.8K |
Jun 11
| |||
Form 4
| +27.78% | 1.75K |
—
|
—
| 8.05K |
May 23
| |||
Form 4
| +38.46% | 1.75K |
—
|
—
| 6.3K |
Jun 7
| |||
Form 4
| +33.82% | 1.15K |
—
|
—
| 4.55K |
Jun 8
| |||
Form 4
| +100.00% | 1.7K |
—
|
—
| 3.4K |
Jun 8
| |||
Form 4
|
∞
| 1.7K |
—
|
—
| 1.7K |
Apr 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
ISTA PHARMACEUTICALS INC No price found
InvestorBenjamin F McGraw III used to own units in Common Stock but no longer holds any shares there. From 2003 to 2012 Benjamin F McGraw III acquired a total of 10,398 shares in ISTA PHARMACEUTICALS INC at a cost of $10.41, Benjamin also disposed a total of 6,432 shares of ISTA PHARMACEUTICALS INC equalling to $58,531.20.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -6.43K |
$9.10 | -$58,531.20 |
0
|
Jun 6
| |||
Form 4/A
| +164.40% | 2.47K |
—
| $2.47 | 3.97K |
Oct 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 7
| |||
Form 4
| +45.12% | 2.47K |
—
| $2.47 | 7.93K |
Dec 10
| |||
Form 4
| +264.40% | 3.97K |
—
| $3.97 | 5.47K |
Oct 20 - Oct 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 13
| |||
Form 4
|
∞
| 1.5K |
—
| $1.50 | 1.5K |
Feb 1 - Oct 20
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Sep 10
| |||
No matching records found |